ホーム>>Signaling Pathways>> DNA Damage/DNA Repair>> DNA Alkylator/Crosslinker>>Carmustine

Carmustine (Synonyms: BCNU, bis-Chloroethylnitrosourea, NSC 409962)

カタログ番号GC15793

カルムスチンは抗腫瘍化学療法剤で、DNA と RNA をアルキル化することによって作用します。

Products are for research use only. Not for human use. We do not sell to patients.

Carmustine 化学構造

Cas No.: 154-93-8

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$43.00
在庫あり
10mg
$39.00
在庫あり
50mg
$70.00
在庫あり
100mg
$126.00
在庫あり
500mg
$490.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Carmustine is an antitumor chemotherapeutic agent, which works by akylating DNA and RNA.

Carmustine is an antitumor chemotherapeutic agent. Carmustine (8, 80, and 800 µM) decreases N-acetyltransferase (NAT) activities for 2-aminofluorene (AF) and p-aminobenzoic acid (PABA) in rat glial tumor cytosol and intact cells. In rat glial tumor cells, the DNA-AF adduct increases, and carmustine decreases the formation of DNA-AF adduct[1].

Carmustine (BCNU; 25 mg/kg, i.p.) causes higher levels of the rhe ratio of liver weight to body weight and plasma conjugated bilirubin, and lower biliary flow, oxidised glutation levels (GSSG) and reduced glutation (GSH)/GSSG values compared with control rats[2].

References:
[1]. Hung CF. Effects of carmustine and lomustine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adducts in rat glial tumor cells. Neurochem Res. 2000 Jun;25(6):845-51.
[2]. Demir A, et al. The effect of trimetazidine on intrahepatic cholestasis caused by carmustine in rats. Hepatol Res. 2001 May 1;20(1):133-143.

レビュー

Review for Carmustine

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Carmustine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.